ZAS Corporation’s esteemed sales division, Zas Critical Care, recently concluded its annual strategic meeting with a resounding success under the theme “Towards Growth.” The gathering was graced by the presence of Zas Corporation’s top executives, including the General Manager and CEO. The meeting showcased the division’s commitment to advancing critical healthcare solutions, aligning with the overarching goal of propelling the company toward unprecedented growth. As Zas Critical Care charts its course for the future, the leadership’s visionary insights and strategic initiatives are set to play a pivotal role in shaping the company’s trajectory within the pharmaceutical industry.
More Releases

ZAS Corporation Ltd. Partners with LABAID Diagnostics and LABAID Cancer Hospital for Employee Healthcare
ZAS Corporation Ltd. is delighted to announce the signing of a Memorandum of Understanding (MOU) with...
|
12 Dec, 2024

ZAS Corporation Introduces Uro-Vaxom to Bangladesh: A Milestone in UTI Prevention
ZAS Corporation proudly launched Uro-Vaxom, an advanced immunotherapeutic solution by OM Pharma, Switzerland,...
|
21 Nov, 2024

ZAS Corporation Hosts Virtual CME on Kidney Transplant Induction Therapy
In collaboration with the Nephrology Department at the National Institute of Kidney Diseases & Urology...
|
04 Nov, 2024

ZAS Corporation Showcases Commitment to Oncology Care at MOSB Congress 2024
ZAS Corporation proudly participated in the prestigious MOSB Congress 2024, reaffirming its dedication...
|
22 Oct, 2024

ZAS Corporation Proudly Sponsors the 178th World Anesthesia Day Celebration with Bangladesh Society of Anaesthesiologists, Critical Care and Pain Physicians
ZAS Corporation was honored to serve as the core sponsor of the 178th World Anesthesia Day celebration,...
|
19 Oct, 2024

ZAS Corporation and Canyon Introduce Microwave Ablation for Fibroids for the First Time in Bangladesh
In a groundbreaking advancement for women’s healthcare in Bangladesh, ZAS Corporation, in collaboration...
|
08 May, 2025

ZAS Ophthalmic Successfully Launches Timo-COMOD and Pollival with Leading Ophthalmologists
ZAS Ophthalmic, a concern of ZAS Group, proudly launched two innovative ophthalmic products — Timo-COMOD...
|
29 Apr, 2025

Round Table Discussion on Preventing Recurrent RTIs in Children
Our Baby Care team recently hosted an engaging and insightful Round Table discussion with leading pediatricians,...
|
13 Jan, 2025

ZAS Corporation Ltd. Signs MOU with The Ibn Sina Trust to Enhance Employee Healthcare Access
ZAS Corporation Ltd. is proud to announce the signing of a Memorandum of Understanding (MOU) with The...
|
12 Dec, 2024

Rise & Refresh: ZAS Corporation’s Inspiring Year-End Retreat to Kuakata
ZAS Corporation Headquarters team wrapped up 2024 with an unforgettable recreation tour to the picturesque...
|
12 Dec, 2024

ZAS Corporation Ltd. Partners with LABAID Diagnostics and LABAID Cancer Hospital for Employee Healthcare
ZAS Corporation Ltd. is delighted to announce the signing of a Memorandum of Understanding (MOU) with...
|
12 Dec, 2024

ZAS Corporation Introduces Uro-Vaxom to Bangladesh: A Milestone in UTI Prevention
ZAS Corporation proudly launched Uro-Vaxom, an advanced immunotherapeutic solution by OM Pharma, Switzerland,...
|
21 Nov, 2024

ZAS Corporation Hosts Virtual CME on Kidney Transplant Induction Therapy
In collaboration with the Nephrology Department at the National Institute of Kidney Diseases & Urology...
|
04 Nov, 2024

ZAS Corporation Showcases Commitment to Oncology Care at MOSB Congress 2024
ZAS Corporation proudly participated in the prestigious MOSB Congress 2024, reaffirming its dedication...
|
22 Oct, 2024

ZAS Corporation Proudly Sponsors the 178th World Anesthesia Day Celebration with Bangladesh Society of Anaesthesiologists, Critical Care and Pain Physicians
ZAS Corporation was honored to serve as the core sponsor of the 178th World Anesthesia Day celebration,...
|
19 Oct, 2024

ZAS Corporation and Canyon Introduce Microwave Ablation for Fibroids for the First Time in Bangladesh
In a groundbreaking advancement for women’s healthcare in Bangladesh, ZAS Corporation, in collaboration...
|
08 May, 2025

ZAS Ophthalmic Successfully Launches Timo-COMOD and Pollival with Leading Ophthalmologists
ZAS Ophthalmic, a concern of ZAS Group, proudly launched two innovative ophthalmic products — Timo-COMOD...
|
29 Apr, 2025

Round Table Discussion on Preventing Recurrent RTIs in Children
Our Baby Care team recently hosted an engaging and insightful Round Table discussion with leading pediatricians,...
|
13 Jan, 2025

ZAS Corporation Ltd. Signs MOU with The Ibn Sina Trust to Enhance Employee Healthcare Access
ZAS Corporation Ltd. is proud to announce the signing of a Memorandum of Understanding (MOU) with The...
|
12 Dec, 2024

Rise & Refresh: ZAS Corporation’s Inspiring Year-End Retreat to Kuakata
ZAS Corporation Headquarters team wrapped up 2024 with an unforgettable recreation tour to the picturesque...
|
12 Dec, 2024